Description:

CALGB: C-215 Secondary Form NCT00085124 Daunorubicin and Cytarabine With or Without Oblimersen in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B229FC8D-B88E-5150-E034-0003BA12F5E7

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B229FC8D-B88E-5150-E034-0003BA12F5E7
Keywords:
  1. 9/19/12 9/19/12 -
  2. 7/29/17 7/29/17 - Martin Dugas
  3. 7/29/17 7/29/17 - Martin Dugas
Uploaded on:

July 29, 2017

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Leukemia Daunorubicin Cytarabine Oblimersen NCT00085124 CALGB

Instructions: This form is to be completed and submitted with each bone marrow or blood sample drawn for evaluation. Unless otherwise indicated use ?-1? to indicate that and answer is ?unknown,? ?unobtainable,? ?not applicable? or ?not done.? Make 2 copies, send original to reference laboratory with sample; send one copy to CALGB Statistical Center, Data Operations and keep a copy for your records.

CALGB C-215 Secondary Form
Are data amended
Has the NCI/CTEP secondary AML/MDS report form been sent to the CALGB central office?

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial